Pharma major Lupin Ltd today said it has entered into a multi-year promotion and marketing management for AeroChamber Plus line of products with Forest Lab Inc.
The product will be promoted among pediatricians through its US-based subsidiary as about two thirds of AeroChamber Plus prescriptions are written by pediatricians, the company said.
AeroChamber is a device used with metered dose inhalers to improve delivery of medication to the lungs in the treatment of asthama among others.
Kamal Sharma, Managing director of Lupin Ltd said the marketing alliance with Forest presents significant opportunity for growth in the US market.
